Ranigast

Q: Is this product safe to consume?

No. This product has been recalled due to: The presence of N-nitrosodimethylamine (NDMA) contamination was confirmed in the active substance ranitidine used to manufacture batches of Ranigast 0.5 mg/ml, solution for infusion, which may pose a potential risk to patients' health. Potencjalne skutki: increased risk of adverse effects, including possible carcinogenic action with long-term exposure.

Q: Which batches are affected?

Affected batch numbers: W3010418

The presence of N-nitrosodimethylamine (NDMA) contamination was confirmed in the active substance ranitidine used to manufacture batches of Ranigast 0.5 mg/ml, solution for infusion, which may pose a potential risk to patients' health. Potencjalne skutki: increased risk of adverse effects, including possible carcinogenic action with long-term exposure.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play

Risk Level

Critical

Manufacturer

Zakłady Farmaceutyczne POLPHARMA S.A.

Batch Number

W3010418

EAN Code

05909990362011

Recall Date

28.10.2019

What You Should Know

Recommendations

Do not use Ranigast 0.5 mg/ml, solution for infusion from the listed batches; if you possess this medicine, check the batch number and return it to a pharmacy or consult a doctor.

Actions Taken

The Chief Pharmaceutical Inspector withdrew the specified batches of Ranigast 0.5 mg/ml, solution for infusion from the market throughout the country and granted the decision immediate enforceability,...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?

No. This product has been recalled due to: The presence of N-nitrosodimethylamine (NDMA) contamination was confirmed in the active substance ranitidine used to manufacture batches of Ranigast 0.5 mg/ml, solution for infusion, which may pose a potential risk to patients' health. Potencjalne skutki: increased risk of adverse effects, including possible carcinogenic action with long-term exposure.

What should I do if I already bought this?

Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.

Which batches are affected?

Affected batch numbers: W3010418

Ranigast

What You Should Know

Recommendations

Actions Taken

Need Help?

Frequently Asked Questions

Other Recalled Products

Lorafen

Carmustine Accord

Taromentin

Plerixafor MSN

Zoledronic Acid Noridem